Effect of magnesium sulphate on urinary catecholamine excretion in severe tetanus

Anaesthesia

Volumn 63, Issue 7, 2008, Pages 719-725

  Thwaites, C L ^a,b   Yen, L M ^c   Cordon, S M ^d   Thwaites, G E ^a,e   Loan, H T ^c   Thuy, T T D ^c   White, N J ^a,b   Soni, N ^f   Macdonald, I A ^d   Farrar, J J ^a,b  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; CATECHOLAMINE; DIAZEPAM; DIGOXIN; MAGNESIUM SULFATE; METRONIDAZOLE; MIDAZOLAM; NORADRENALIN; PIPECURONIUM; PLACEBO; TETANUS ANTIBODY; VERAPAMIL;

ADRENALIN URINE LEVEL; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR PARAMETERS; CATECHOLAMINE EXCRETION; CATECHOLAMINE URINE LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MUSCLE SPASM; NORADRENALIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; TETANUS; TREATMENT OUTCOME; URINARY EXCRETION; WOUND CARE;

EID: 44949090373     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05476.x     Document Type: Article

References (15)

1. World Health Organisation. Neurological disorders: public health challenges. 2006.
2. Kerr JH, Corbett JL, Prys-Roberts C, Smith AC, Spalding JM. Involvement of the sympathetic nervous system in tetanus. Studies on 82 cases. Lancet 1968 2 : 236 41.
3. Dastur FD, Bhat GJ, Nair KG. Autonomic dysfunction as a problem in the treatment of tetanus. Progress in Drug Research 1975 19 : 245 51.
4. King WW, Cave DR. Use of esmolol to control autonomic instability of tetanus. American Journal of Medicine 1991 91 : 425 8.
5. James MF, Manson ED. The use of magnesium sulphate infusions in the management of very severe tetanus. Intensive Care Medicine 1985 11 : 5 12.
6. Kelty SR, Gray RC, Dundee JW, McCullouch H. Catecholamine levels in severe tetanus. Lancet 1968 2 : 195.
7. Thwaites CL, Yen LM, Cordon SM, et al. Urinary catecholamine excretion in tetanus. Anaesthesia 2006 61 : 355 9.
8. von Euler US, Lishajko F. Effects of Mg2 + and Ca2 + on noradrenaline release and uptake in adrenergic nerve granules in differential media. Acta Physiologica Scandinavica 1973 89 : 415 22.
9. Douglas WW, Rubin RP. The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus-secretion coupling. Journal of Physiology 1963 167 : 288 310.
10. James MF. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics. British Journal of Anaesthesia 1989 62 : 616 23.
11. James MF, Beer RE, Esser JD. Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation. Anesthesia and Analgesia 1989 68 : 772 6.
12. Thwaites CL, Yen LM, Loan HT, et al. Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. Lancet 2006 368 : 1436 43.
13. Forster CD, Macdonald IA. The assay of the catecholamine content of small volumes of human plasma. Biomedical Chromatography 1999 13 : 209 15.
14. Blake JA. The use of magnesium sulphate in the production of anaesthesia and in the treatment of tetanus. Surgery Gynecology and Obstetrics 1906 2 : 541 50.
15. Pasternak K, Dabrowski W, Dobija J, Wronskal J, Rzecki Z, Biernacka J. The effect of preoperative magnesium supplementation on blood catecholamine concentrations in patients undergoing CABG. Magnesium Research 2006 19 : 113 22.